03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Actrapid Novolet* : | |
Type | Medicine Non Marketed |
Originator | Biotech (Insuman Rapid) |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Novo Nordisk |
Responsible Party | Novo Nordisk AS |
Origin | Denmark |
Manufacturer | Novo Nordisk AS |
Origin | Denmark |
ATC | A10AB01 |
Actrapid Novolet* :
Actrapid Novolet* :
Actrapid Novolet* :
Actrapid Novolet* :
Actrapid Novolet* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Actrapid Novolet* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Anaphylactic reactions | Very rare |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Very rare |
Blood pressure decreased | Very rare |
Diabetic retinopathy | Very rare |
Difficulty breathing | Very rare |
Gastrointestinal upset | Very rare |
Hypersensitivity reactions | Very rare |
Hypoglycaemia | Very Common |
Injection site bruising | Not known |
Injection site inflammation | Not known |
Injection site itching | Not known |
Injection site pain | Not known |
Injection site reaction | Uncommon |
Injection site redness | Not known |
Injection site swelling | Not known |
Injection site urticaria | Not known |
Itching | Very rare |
Lipoatrophy | Uncommon |
Lipodystrophy | Uncommon |
Lipohypertrophy | Uncommon |
Neuropathy peripheral | Uncommon |
Oedema | Uncommon |
Palpitations | Very rare |
Rash generalised | Very rare |
Refraction disorder | Uncommon |
Skin rash | Uncommon |
Sweating | Very rare |
Urticaria | Uncommon |
Actrapid Novolet* :
NB : Products With Same Indication |
Different Units By MoH Code
Actrapid Novolet* MoH 2007 :
Form | Solution for injection |
Packaging | Disposable pen with cartridge ( glass) |
Package Size | 5x3ml |
Strength | 100IU/ml |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 405544/00 |
Submission date | 01/01/2000 |
Registration Year | 2000 |
Archived Date | 2014 |
Price Comparison
● Country: | KSA | |
● Package Size: | 5x3ml | |
● Public Price: | 166.35 SAR | ( 3,932,514.00 LBP ) |
● Pack size unit used: | 1500 | |
● Cost/Unit: | 0,1109 SAR | ( 0.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 05/03/2020 | |
● Type: | Medicine Non Marketed |
You have to register to view this info
Drop File